Scarica l'app Stockscreener
20.31
0.68%
-0.14
Pre-mercato:
20.89
0.58
+2.86%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$20.45
Aprire:
$19.805
Volume 24 ore:
411.54K
Relative Volume:
0.72
Capitalizzazione di mercato:
$551.51M
Reddito:
$157.75M
Utile/perdita netta:
$-29.73M
Rapporto P/E:
-17.51
EPS:
-1.16
Flusso di cassa netto:
$-21.00M
1 W Prestazione:
+3.52%
1M Prestazione:
+14.68%
6M Prestazione:
+59.04%
1 anno Prestazione:
-4.69%
Intervallo 1D:
$19.56
$20.50
Intervallo di 1 settimana:
$19.53
$21.66
Portata 52W:
$8.04
$25.88
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Nome
Arcturus Therapeutics Holdings Inc
Settore
Industria
Telefono
(858) 900-2660
Indirizzo
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Confronta ARCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
20.31 | 555.31M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-28 | Iniziato | Scotiabank | Sector Outperform |
| 2025-01-28 | Iniziato | BTIG Research | Buy |
| 2024-08-12 | Iniziato | Leerink Partners | Outperform |
| 2023-12-13 | Iniziato | Canaccord Genuity | Buy |
| 2023-07-24 | Iniziato | William Blair | Outperform |
| 2023-05-11 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | Ripresa | Wells Fargo | Overweight |
| 2022-11-10 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-11-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-08-10 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | Ripresa | Cantor Fitzgerald | Overweight |
| 2022-05-11 | Aggiornamento | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | Downgrade | Citigroup | Buy → Neutral |
| 2022-01-31 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | Downgrade | Goldman | Neutral → Sell |
| 2021-08-10 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-06-25 | Ripresa | Goldman | Neutral |
| 2021-06-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2021-06-04 | Ripresa | Robert W. Baird | Neutral |
| 2021-02-17 | Downgrade | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | Iniziato | Wells Fargo | Overweight |
| 2020-12-29 | Downgrade | Barclays | Overweight → Equal Weight |
| 2020-12-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | Downgrade | ROTH Capital | Buy → Sell |
| 2020-12-08 | Reiterato | B. Riley Securities | Buy |
| 2020-12-07 | Reiterato | B. Riley Securities | Buy |
| 2020-10-26 | Iniziato | Barclays | Overweight |
| 2020-10-06 | Iniziato | Citigroup | Buy |
| 2020-08-26 | Iniziato | Piper Sandler | Overweight |
| 2020-07-30 | Ripresa | ROTH Capital | Buy |
| 2020-07-16 | Iniziato | Raymond James | Outperform |
| 2020-07-13 | Iniziato | B. Riley FBR | Buy |
| 2020-06-09 | Downgrade | WBB Securities | Buy → Hold |
| 2020-02-11 | Iniziato | Robert W. Baird | Outperform |
| 2020-02-07 | Iniziato | Guggenheim | Buy |
| 2020-02-06 | Iniziato | Guggenheim | Buy |
| 2019-04-05 | Iniziato | H.C. Wainwright | Buy |
| 2018-09-20 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Arcturus Therapeutics Holdings Inc Borsa (ARCT) Ultime notizie
Cathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus Stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus Stock - Investing.com
Arcturus Sues AbbVie, Capstan Alleging Trade Secret Theft - Law360
ARK Investment Expands Stake with Purchase in Arcturus Therapeutics (ARCT) - GuruFocus
Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating - Seeking Alpha
Arcturus Therapeutics (NASDAQ:ARCT) Trading Up 5.4%Here's What Happened - MarketBeat
We're Not Very Worried About Arcturus Therapeutics Holdings' (NASDAQ:ARCT) Cash Burn Rate - 富途牛牛
Goldman Sachs Group Inc. Buys 42,636 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Published on: 2025-09-20 08:03:53 - khodrobank.com
Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? - Yahoo Finance
Dynamic Technology Lab Private Ltd Takes $299,000 Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - MSN
Arcturus Therapeutics Holdings Inc. $ARCT Shares Bought by Jacobs Levy Equity Management Inc. - MarketBeat
Highs Report: Is Arcturus Therapeutics Holdings Inc backed by strong institutional buying2025 Dividend Review & Free Reliable Trade Execution Plans - خودرو بانک
Woodline Partners LP Sells 26,470 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Risk Analysis: What’s the beta of Arcturus Therapeutics Holdings Inc. stockGDP Growth & AI Based Buy/Sell Signal Reports - خودرو بانک
Shorts Report: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesEarnings Beat & Capital Protection Trading Alerts - khodrobank.com
Analyst Calls: Can Arcturus Therapeutics Holdings Inc sustain its profitability2025 Market Sentiment & Technical Pattern Based Signals - خودرو بانک
Decliners Report: Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersPortfolio Update Summary & Stock Timing and Entry Methods - خودرو بانک
Inflation Data: Can Arcturus Therapeutics Holdings Inc sustain its profitabilityWeekly Trend Summary & AI Enhanced Trading Signals - خودرو بانک
US Stocks Recap: Is Arcturus Therapeutics Holdings Inc. affected by consumer sentimentJuly 2025 Market Mood & Growth Focused Entry Reports - خودرو بانک
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth - Nasdaq
Will Arcturus Therapeutics Holdings Inc. benefit from macro trendsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Applying Elliott Wave Theory to Arcturus Therapeutics Holdings Inc.July 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Applying big data sentiment scoring on Arcturus Therapeutics Holdings Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Visualizing Arcturus Therapeutics Holdings Inc. stock with heatmaps2025 Year in Review & Stepwise Trade Signal Guides - newser.com
Arcturus Therapeutics Holdings Inc. stock prediction for this weekIndex Update & Free Community Supported Trade Ideas - newser.com
Will Arcturus Therapeutics Holdings Inc. stock recover after recent dropJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
What is HC Wainwright's Estimate for ARCT Q3 Earnings? - MarketBeat
Invesco Ltd. Acquires 15,836 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Nuveen LLC Takes $635,000 Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Will Arcturus Therapeutics Holdings Inc. benefit from rate cuts2025 Price Momentum & Capital Efficient Trade Techniques - beatles.ru
Vestal Point Capital LP Acquires New Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Real time alert setup for Arcturus Therapeutics Holdings Inc. performanceWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Arcturus Therapeutics Holdings Inc. backed by strong institutional buyingJuly 2025 PreEarnings & Weekly Top Stock Performers List - خودرو بانک
American Century Companies Inc. Increases Stock Position in Arcturus Therapeutics Holdings Inc. $ARCT - Defense World
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Rating of "Buy" by Analysts - MarketBeat
Applying sector rotation models to Arcturus Therapeutics Holdings Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser
Automated trading signals detected on Arcturus Therapeutics Holdings Inc. - Newser
What’s the beta of Arcturus Therapeutics Holdings Inc. stock2025 Volume Leaders & Weekly Watchlist of Top Performers - خودرو بانک
Is Arcturus Therapeutics Holdings Inc. stock undervalued right nowJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Does Arcturus Therapeutics Holdings Inc. qualify in momentum factor screeningEarnings Recap Summary & Smart Money Movement Alerts - Newser
Arcturus Therapeutics Holdings Inc. recovery potential after sell offMarket Activity Recap & Precise Entry and Exit Recommendations - Newser
What Fibonacci levels say about Arcturus Therapeutics Holdings Inc. reboundEarnings Overview Report & Reliable Intraday Trade Plans - Newser
Live market analysis of Arcturus Therapeutics Holdings Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Multi factor analysis applied to Arcturus Therapeutics Holdings Inc.Dip Buying & Long-Term Growth Stock Strategies - Newser
Tools to monitor Arcturus Therapeutics Holdings Inc. recovery probabilityMarket Trend Review & High Conviction Buy Zone Picks - Newser
Relative strength of Arcturus Therapeutics Holdings Inc. in sector analysis2025 Support & Resistance & Weekly Momentum Picks - Newser
Arcturus Therapeutics Holdings Inc Azioni (ARCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):